Project Description

Gamida Cell (with Novartis recently joining as a strategic investor) is a world leader in stem-cell therapy products for transplantation and regenerative medicine. NiCord® is a breakthrough therapy for millions of patients with blood cancers, autoimmune diseases, and non-malignant hematological diseased, all currently with no other hope of a cure..